Soleus Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-120,000	Closed	-$2.59M	–	93
2023 Q2	$2.59M	Buy	120,000 +56,786	+90%	+$1.22M	0.29%	64
2023 Q1	$1.85M	Buy	63,214 +12,578	+25%	+$369K	0.19%	65
2022 Q4	$1.87M	Sell	50,636 -378,700	-88%	-$14M	0.27%	60
2022 Q3	$12.1M	Buy	+429,336	New	+$12.1M	1.64%	19